This state-of-the-art MRI machine produces better, faster, and less expensive images of the human body, thus improving the capability of diagnostic imaging to detect diseases. By Justin Chapman The state-of-the-art magnetic resonance imaging (MRI)...
Dr. Wayne Koff, founder and CEO of the Human Immunome Project, discusses the origin of the Michelson Prizes, and Phillip Kim, CEO of Michelson 20MM Foundation, provides an update on the organization’s recent impact venture investments that aim to make the world a...
The John O’Brien Nanofabrication Lab is a hub for research projects ranging from basic science to applied technology, including lithography, characterization, imaging, and device integration resources. By Justin Chapman USC Professor Andrea Armani...
A team of scientists have for the first time looked at a pancreatic cell as it was packaging insulin and responding to a drug treatment. A team of scientists—led by researchers at the Bridge Institute at the USC Michelson Center for Convergent...
Epic Sciences and Peter Kuhn's CTC Technology Collaboration Epic Sciences, Inc. has entered into an exclusive license and collaboration agreement with Peter Kuhn, Ph.D., and the USC Michelson Center for Convergent Bioscience. Dr. Kuhn is a founding member of...
Even though scientific knowledge about COVID-19 grows by the day, the mysteries of the disease’s progression remain a major hurdle in stemming the pandemic. Researchers at the USC Michelson Center for Convergent Bioscience are helping unlock these secrets...
Dr. Gary K. Michelson delivers the keynote address at the groundbreaking of the USC Michelson Center for Convergent Bioscience.